Statera Biopharma
Financial ratios & Valuation

Historical Multiples (2013 – 2021)

2013 2014 2015 2016 2017 2018 2019 2020 2021 TTM Median
Valuation Ratios
Price/Earnings ratio
-61.009.45-1.94-5.86-4.62-3.15-4.61-6.69-0.46-0.00-5.24
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A0.26N/A
Price/Book Value ratio
-110.58-15.342.492.0720.40-7.85-3.66-24.20-51.49-0.0710.16
Price/Cash Flow ratio
-45.58-1.06-2.03-3.09-6.78-2.47-64.23-17.41-2.86-0.06-4.94
Price/Free Cash Flow ratio
-45.58-1.06-2.03-3.09-6.78-2.47-64.23-17.37-2.84-0.06-4.94
Price/Earnings Growth ratio
2.71-0.030.000.06-0.010.040.07-0.02-0.000.000.02
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/A63.66%N/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/A-3100.33%N/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/A-3249.39%N/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/A-3249.12%N/A
Effective Tax Rate
N/AN/AN/A0.85%0.54%4.46%-3.85%-9.34%-71.19%N/A2.50%
Return on Assets
-117.46%45.91%-60.52%-16.66%-100.80%-79.65%-202924.54%-1277.13%-823.85%-768.93%-90.22%
Return On Equity
181.27%-162.29%-127.80%-35.33%-441.25%248.76%79.53%361.74%11122.70%1842.43%-238.29%
Return on Capital Employed
-264.94%-228.05%-71.75%-49.47%-75.52%-132.50%66.84%292.90%-990.93%986.51%-62.49%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A0.05N/A
Quick Ratio
1.80-1.173.545.114.324.900.100.200.360.034.61
Cash ratio
1.67-0.531.012.211.913.960.000.120.160.022.93
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/A43.72N/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/A10.78N/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/AN/AN/A2.96K2.70KN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/A-2.66KN/A
Debt Ratios
Debt Ratio
0.492.06N/AN/AN/AN/A1.09K1.830.711.79N/A
Debt Equity Ratio
-0.75-7.30N/AN/AN/AN/A-0.42-0.52-9.69-2.23N/A
Long-term Debt to Capitalization
-2.971.15N/AN/AN/AN/AN/AN/A1.17-0.07N/A
Total Debt to Capitalization
-3.121.15N/AN/AN/AN/A-0.75-1.081.11-2.61N/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A-8.31N/A
Cash Flow to Debt Ratio
-3.20-1.97N/AN/AN/AN/A-0.13-2.67-1.85-1.73N/A
Company Equity Multiplier
-1.54-3.532.112.124.37-3.12-0.00-0.28-13.50-1.240.62
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A-4.26N/A
Free Cash Flow / Operating Cash Flow Ratio
11111111.001.001.001
Cash Flow Coverage Ratio
-3.20-1.97N/AN/AN/AN/A-0.13-2.67-1.85-1.73N/A
Short Term Coverage Ratio
-276.23N/AN/AN/AN/AN/A-0.13-2.67-6.16-1.91N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A